# HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer

> **NCT02464137** · PHASE1 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 15 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Larynx

## Interventions

- **RADIATION:** radiation

## Key facts

- **NCT ID:** NCT02464137
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04-27
- **Primary completion:** 2019-03-04
- **Final completion:** 2019-03-04
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** unexpected toxicities
- **Last updated:** 2020-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02464137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02464137, "HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02464137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*